Anebulo Pharmaceuticals Inc Net Asset Momentum
Anebulo Pharmaceuticals Inc net asset momentum. Anebulo Pharmaceuticals Inc (ANEB) recorded a net asset momentum of 205.8% as of June 2025, with net assets of $11.66 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore ANEB debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Anebulo Pharmaceuticals Inc (2020–2025)
Net asset momentum of Anebulo Pharmaceuticals Inc from 2020 to 2025. This chart tracks Anebulo Pharmaceuticals Inc's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +205.8%, with net assets of $11.66 Million USD as of June 2025. See ANEB total equity for net asset value and shareholders' equity analysis.
Anebulo Pharmaceuticals Inc Net Asset Momentum by Year (2020–2025)
Anebulo Pharmaceuticals Inc net asset momentum by year from 2020 to 2025. The table below shows the complete annual net asset history for Anebulo Pharmaceuticals Inc from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see Anebulo Pharmaceuticals Inc stock valuation.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $11.66 Million | $12.15 Million | $487.69K | ▲ +205.8% |
| 2024 | $3.81 Million | $4.07 Million | $260.58K | ▼ -64.0% |
| 2023 | $10.60 Million | $11.67 Million | $1.07 Million | ▼ -29.6% |
| 2022 | $15.07 Million | $15.58 Million | $512.53K | ▼ -29.6% |
| 2021 | $21.41 Million | $21.65 Million | $241.63K | ▲ +663.5% |
| 2020 | $2.80 Million | $3.03 Million | $223.87K | — |